Timothy Schmid - 13 Feb 2026 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WW Chair, MedTech
Signature
/s/ Joleen Morgan, as attorney-in-fact for Timothy Schmid
Issuer symbol
JNJ
Transactions as of
13 Feb 2026
Net transactions value
-$3,344,948
Form type
4
Filing time
18 Feb 2026, 21:11:43 UTC
Previous filing
11 Feb 2026
Next filing
23 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schmid Timothy EVP, WW Chair, MedTech ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK /s/ Joleen Morgan, as attorney-in-fact for Timothy Schmid 18 Feb 2026 0001998491

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +499 +2.3% $0.000000 22,624 13 Feb 2026 Direct F1
transaction JNJ Common Stock Tax liability $1,956 -8 -0.04% $244.55 22,616 13 Feb 2026 Direct F2
transaction JNJ Common Stock Options Exercise $0 +4,378 +19% $0.000000 26,994 13 Feb 2026 Direct F3
transaction JNJ Common Stock Tax liability $444,103 -1,816 -6.7% $244.55 25,178 13 Feb 2026 Direct F4
transaction JNJ Common Stock Options Exercise $0 +1,028 +4.1% $0.000000 26,206 15 Feb 2026 Direct F5
transaction JNJ Common Stock Tax liability $3,652 -15 -0.06% $243.45 26,191 15 Feb 2026 Direct F2
transaction JNJ Common Stock Options Exercise $0 +1,026 +3.9% $0.000000 27,217 15 Feb 2026 Direct F6
transaction JNJ Common Stock Tax liability $109,066 -448 -1.6% $243.45 26,769 15 Feb 2026 Direct F2
transaction JNJ Common Stock Options Exercise $1,576,004 +13,625 +51% $115.67 40,394 18 Feb 2026 Direct
transaction JNJ Common Stock Sale $3,327,225 -13,625 -34% $244.20 26,769 18 Feb 2026 Direct F7
transaction JNJ Common Stock Options Exercise $1,165,331 +8,998 +34% $129.51 35,767 18 Feb 2026 Direct
transaction JNJ Common Stock Sale $2,200,281 -8,998 -25% $244.53 26,769 18 Feb 2026 Direct
holding JNJ Common Stock 745 13 Feb 2026 By 401k F8
holding JNJ Common Stock 46 13 Feb 2026 By ESOP F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -499 -100% $0.000000 0 13 Feb 2026 Common Stock 499 Direct F1
transaction JNJ Performance Share Units Options Exercise $0 -4,378 -100% $0.000000 0 13 Feb 2026 Common Stock 4,378 Direct F3
transaction JNJ Restricted Share Units Options Exercise $0 -1,028 -50% $0.000000 1,028 15 Feb 2026 Common Stock 1,028 Direct F5, F10
transaction JNJ Restricted Share Units Options Exercise $0 -1,026 -33% $0.000000 2,051 15 Feb 2026 Common Stock 1,026 Direct F6, F10
transaction JNJ Employee Stock Options (Right to Buy) Award $0 +35,489 $0.000000 35,489 15 Feb 2026 Common Stock 35,489 $243.45 Direct F11
transaction JNJ Restricted Share Units Award $0 +2,548 $0.000000 2,548 15 Feb 2026 Common Stock 2,548 Direct F10, F12
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -13,625 -100% $0.000000 0 18 Feb 2026 Common Stock 13,625 $115.67 Direct F13
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -8,998 -100% $0.000000 0 18 Feb 2026 Common Stock 8,998 $129.51 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.
F2 Shares withheld for payment of taxes upon vesting of RSUs.
F3 Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting.
F4 Shares withheld for payment of taxes upon vesting of PSUs.
F5 Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.
F6 Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
F7 This transaction was executed in multiple trades at prices ranging from $244.20 to $244.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).
F9 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).
F10 Each RSU represents a contingent right to receive one share of Company Common Stock.
F11 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.
F12 Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
F13 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date.